In the latest analyze, we noted the identification and the characterization of a completely new atypical opioid receptor with unique adverse regulatory Houses to opioid peptides.one Our effects showed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be a broad-spectrum scavenger for